No shared counterparties.
| Stage | NVDA | % of rev | MPWR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $96.2B | 100.00% | $981M | 100.00% | NVDA ×98.12 |
| Gross profit | $72.1B | 74.98% | $541M | 55.18% | NVDA +19.8pp |
| Operating income | $63.7B | 66.24% | $304M | 30.99% | NVDA +35.2pp |
| Pre-tax income | $71.5B | 74.32% | $322M | 32.81% | NVDA +41.5pp |
| Net income | $59.7B | 62.03% | $257M | 26.24% | NVDA +35.8pp |
| Stage | NVDA | MPWR | Gap · A − B |
|---|---|---|---|
| Revenue | $96.2B100.00% | $981M100.00% | NVDA ×98.12 |
| Gross profit | 74.98%$72.1B | 55.18%$541M | NVDA +19.8pp |
| Operating income | 66.24%$63.7B | 30.99%$304M | NVDA +35.2pp |
| Pre-tax income | 74.32%$71.5B | 32.81%$322M | NVDA +41.5pp |
| Net income | 62.03%$59.7B | 26.24%$257M | NVDA +35.8pp |